Literature DB >> 21739256

A theory and a model to understand glioblastoma development both in the bulk and in the microinfiltrated brain parenchyma.

Enrico Brognaro1.   

Abstract

The prognosis of patients affected by glioblastoma remains dismal despite many efforts have been devoted worldwide in research and therapeutic strategies. Reasons of our failure include the fact that the patient harboring a glioblastoma always has two problems inside the brain, the bulk tumor and the parenchyma microinfiltrated; the other reason is that the tumor is able to grow dynamically adapting to the mutated conditions of its growth microenvironment. This paper tries to give an interpretation to the dynamic process of the tumor growth, from the beginning to the end of its natural history, dividing it in three phases, one pre-hypoxia and two post-hypoxia, and these are then correlated with the types of cancer stem cells (CSCs) involved. Furthermore, the paper proposes an original animal model to follow glioblastoma development in only one generation of mice, both in the bulk and in the brain parenchyma.

Entities:  

Mesh:

Year:  2011        PMID: 21739256     DOI: 10.1007/s11064-011-0539-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  42 in total

1.  EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells.

Authors:  Fiona Doetsch; Leopoldo Petreanu; Isabelle Caille; Jose Manuel Garcia-Verdugo; Arturo Alvarez-Buylla
Journal:  Neuron       Date:  2002-12-19       Impact factor: 17.173

2.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

3.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

4.  Targeting cancer stem cells through L1CAM suppresses glioma growth.

Authors:  Shideng Bao; Qiulian Wu; Zhizhong Li; Sith Sathornsumetee; Hui Wang; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

Review 5.  The role of hypoxia-induced factors in tumor progression.

Authors:  Peter Vaupel
Journal:  Oncologist       Date:  2004

6.  Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines.

Authors:  Corinne E Griguer; Claudia R Oliva; G Yancey Gillespie
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

7.  Hypoxia is important in the biology and aggression of human glial brain tumors.

Authors:  Sydney M Evans; Kevin D Judy; Isolde Dunphy; W Timothy Jenkins; Wei-Ting Hwang; Peter T Nelson; Robert A Lustig; Kevin Jenkins; Deirdre P Magarelli; Stephen M Hahn; Ruth A Collins; M Sean Grady; Cameron J Koch
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

Review 8.  Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis.

Authors:  Peter Vaupel
Journal:  Oncologist       Date:  2008

9.  Influence of oxygen tension on CD133 phenotype in human glioma cell cultures.

Authors:  Nadine Platet; Shi Yong Liu; Michèle El Atifi; Lisa Oliver; François M Vallette; François Berger; Didier Wion
Journal:  Cancer Lett       Date:  2007-10-30       Impact factor: 8.679

10.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

Authors:  Zhizhong Li; Shideng Bao; Qiulian Wu; Hui Wang; Christine Eyler; Sith Sathornsumetee; Qing Shi; Yiting Cao; Justin Lathia; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

View more
  1 in total

1.  "The development tumor model" to study and monitor the entire progression of both primary and metastatic tumors.

Authors:  Enrico Brognaro
Journal:  Tumour Biol       Date:  2013-11-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.